A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

NCT03242018 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Chronic Kidney Disease Stage 4

Interventions

DRUG: Placebo
DRUG: Sotagliflozin

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]